Form 4 Tracker
Eric Venker

Director, Chief Executive Officer; President & Immunovant CEO · 8 filings · Latest: Jun 24, 2026

Immunovant, Inc.
Roivant Sciences Ltd.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ROIV
Venker EricDec 9, 2025
Proposed Sale
$20.85200,000$4.2M
ROIV
Venker EricNov 7, 2025
Proposed Sale
$20.22200,000$4.0M
ROIV
Venker EricOct 17, 2025
Proposed Sale
$17.06118,418$2.0M
ROIV
Venker EricOct 16, 2025
Proposed Sale
$17.05318,282$5.4M
ROIV
Venker EricOct 15, 2025
Proposed Sale
$16.93414,683$7.0M
ROIV
Venker EricOct 13, 2025
Proposed Sale
$16.2520,727$336.9K
ROIV
Venker EricOct 9, 2025
Proposed Sale
$16.30104,940$1.7M
ROIV
Venker EricOct 8, 2025
Proposed Sale
$16.20138,602$2.2M
ROIV
Venker EricOct 7, 2025
Proposed Sale
$16.15355,161$5.7M
ROIV
Venker EricOct 6, 2025
Proposed Sale
$16.34171,396$2.8M
ROIV
Venker EricSep 23, 2025
Proposed Sale
$14.94611,079$9.1M
ROIV
ERIC VENKERSep 22, 2025
Proposed Sale
$14.99316,182$4.7M
ROIV
Venker EricSep 22, 2025
Proposed Sale
$15.01100,000$1.5M
ROIV
ERIC VENKERSep 19, 2025
Proposed Sale
$14.95683,818$10.2M
ROIV
Venker EricAug 20, 2025
Proposed Sale
$11.72100,000$1.2M
ROIV
Venker EricJul 21, 2025
Proposed Sale
$11.52100,000$1.2M
ROIV
Venker EricJun 20, 2025
Proposed Sale
$11.45100,000$1.1M
ROIV
ERIC VENKERJun 3, 2025
Proposed Sale
$11.22566,278$6.4M
ROIV
ERIC VENKERJun 2, 2025
Proposed Sale
$11.07433,722$4.8M
ROIV
Venker EricMay 20, 2025
Proposed Sale
$10.95100,000$1.1M